Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Inflammatory Bowel Disease (IBD) Therapeutics
... is expected to reach US$32.8 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. TNF inhibitors, one of the segments analyzed in the report, is expected to record a 5.9% ... Read More
-
Global Schizophrenia Drugs Market Report by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) Treatment (Injectable, Oral) Therapeutic Class (Second Generation, Third Generation, Others) Countries and Company Analysis, 2024-2032
... drugs market will increase from US$ 7,433.1 million in 2030 to over US$ 10,132.4 million by 2032 with a CAGR of 3.50% from 2024 to 2032. This growth is as a result of the growing ... Read More
-
High Content Screening (HCS)
... reach US$2.2 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2023-2030. HCS Instruments, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach ... Read More
-
Biosimulation Technology
... at a CAGR of 15.7% over the analysis period 2023-2030. Biosimulation Software, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$5.7 Billion by the end of ... Read More
-
Acute Heart Failure (AHF) Therapeutics
... is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 21.3% over the analysis period 2023-2030. Cardiac Glycosides, one of the segments analyzed in the report, is expected to record a 21.8% ... Read More
-
Osteoporosis Therapeutics
... at a CAGR of 2.8% over the analysis period 2023-2030. Bisphosphonates Drug Class, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$8.1 Billion by the end ... Read More
-
Prader-Willi Syndrome Market Insight, Epidemiology And Market Forecast - 2034
... that, with the right strategy, it has the potential to be very profitable. In 2023, the total market size of hidradenitis suppurativa was nearly USD ~1,400 million in the 7MM. The largest market size was ... Read More
-
Janus Kinase (JAK) Inhibitor- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Narcolepsy Therapeutics
... at a CAGR of 7.2% over the analysis period 2023-2030. Narcolepsy with Cataplexy Therapeutics, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.9 Billion by the ... Read More
-
Huntington`s Disease Therapeutics
... by 2030, growing at a CAGR of 31.5% over the analysis period 2023-2030. The U.S. Market is Estimated at US$787.6 Million While China is Forecast to Grow at 40.2% CAGR The Huntington`s Disease Therapeutics market ... Read More
-
Irritable Bowel Syndrome (IBS) Therapeutics
... is expected to reach US$3.4 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. IBS-D Therapeutics, one of the segments analyzed in the report, is expected to record a 6.9% ... Read More
-
Fibromyalgia Therapeutics
... at a CAGR of 3.0% over the analysis period 2023-2030. Antiepileptics Drug Class, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$2.1 Billion by the end ... Read More
-
Apoptosis
... of 4.6% over the analysis period 2023-2030. Apoptosis Assay Kits, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.9 Billion by the end of the analysis ... Read More
-
Advanced Wound Care (AWC) - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Devices [Negative Pressure Wound Therapy Devices, Hyperbaric Oxygen Therapy Devices, Debridement Devices, and Others], Grafts & Matrices), Wound Type (Surgical & Traumatic Wounds, Diabetic Foot Ulcers, Burns, Others), End-User (Hospitals, Specialty Clinics, and Others), and ... Read More
-
Anemia Drugs
... at a CAGR of 4.1% over the analysis period 2023-2030. Iron Deficiency Anemia Drugs, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$7.4 Billion by the ... Read More
-
Endometriosis Drugs
... at a CAGR of 3.0% over the analysis period 2023-2030. Hormone Therapy, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.2 Billion by the end of ... Read More
-
Tinea Pedis (Athlete`s Foot) Treatment
... is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2023-2030. Topical Administration, one of the segments analyzed in the report, is expected to record a 3.3% ... Read More
-
Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
... & Trends The global nuclear medicine market size is expected to reach USD 34.51 billion by 2030, registering a CAGR of 11.69% from 2024 to 2030, according to a new report by Grand View Research, ... Read More
-
Shingles - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Shingles: Understanding ... Read More
-
Urticaria- Pipeline Insight, 2024
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Urticaria: Understanding Urticaria: Overview ... Read More
-
Contraceptive Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the escalating incidence of unintended pregnancies, increased awareness and education ... Read More
-
Rnai Technology Market, By Application (Drug Discovery and Development, Therapeutics, Functional Genomics, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CMOs, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Asia Pacific, Middle East & Africa) Global RNAi technology market growth is driven by growing applications of RNA interference technology in therapeutics development and research. RNA interference or RNAi refers to the process of gene ... Read More
-
Alopecia Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Settings, Dermatology Clinics, And Others) And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of alopecia, and ... Read More
-
Cancer/Tumor Profiling Market Report by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In-Situ Hybridization (ISH), Microarray, and Others), Technique (Genomics, Proteomics, Epigenetics, Metabolomics), Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, and Others), and Region 2024-2032
... Technique (Genomics, Proteomics, Epigenetics, Metabolomics), Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, and Others), and Region 2024-2032 The global cancer/tumor profiling market size reached US$ 11.5 Billion in 2023. Looking forward, IMARC Group expects the ... Read More
-
Anti-Tuberculosis Therapeutics Market Report by Disease Type (Active TB, Latent TB, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2024-2032
... reached US$ 1,445.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,448.5 Million by 2032, exhibiting a growth rate (CAGR) of 5.85% during 2024-2032. The rising healthcare spending, favorable reimbursement ... Read More
Research Assistance
